 REDWOOD CITY, CA ACCESSWIRE May 20, 2020 Avinger, Inc. AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease PAD, today announced the Company has submitted a 510k application to the U.S. Food Drug Administration FDA for pre-marketing clearance of Ocelaris, a next generation chronic total occlusion CTO crossing system utilizing Avingers proprietary image-guided technology platform. Ocelaris is a product line extension of Avingers Ocelot family of image-guided CTO crossing catheters. Its design elements include an upgrade of the image capture rate to provide high definition, real-time intravascular imaging similar to the companys Pantheris image-guided atherectomy system and a user-controlled deflectable tip designed to assist in steerability within the lumen. 